PacBio and DNAstack Unite to Accelerate Rare Disease Discovery Through Federated HiFi Sequencing

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies,  announced a collaboration with DNAstack to power the wor...

February 26, 2026 | Thursday | News
Redefining CNS Therapeutics: A Conversation with Joel Latham on Incannex Healthcare’s Clinical Vision

    Under the leadership of Joel Latham, Incannex Healthcare is advancing a differentiated pipeline of cannabinoid- and psychedelic-based thera...

March 02, 2026 | Monday | Interaction
Bayer Sues Johnson & Johnson And Janssen Biotech Over Allegedly Misleading Prostate Cancer Drug Data

Bayer files false advertising suit against J&J and Janssen Biotech Lawsuit seeks preliminary and permanent injunctions in addition to damages. ...

February 25, 2026 | Wednesday | News
Organon Strengthens Women’s Health Portfolio With Exclusive MIUDELLA Licensing Agreement

MIUDELLA® is a strategic addition to Organon’s portfolio, strengthening its long‑term commitment to advancing women’s health ...

February 25, 2026 | Wednesday | News
IDT Launches Next-Generation Sequencing Innovations To Streamline Cancer Genomics Workflows

New innovations designed to simplify NGS workflows Enhances critical variant identification through improved technologies Roadmap advances provide flex...

February 25, 2026 | Wednesday | News
Dr. Reddy’s Advances Biosimilar Pipeline with FDA Review Acceptance for DRL_AB

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “D...

February 24, 2026 | Tuesday | News
Sai Life Sciences Announces Major Talent Expansion as Global Outsourcing Momentum Accelerates

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development and manufacturing organiza...

February 24, 2026 | Tuesday | News
Abbott Secures Shareholder Approval for Exact Sciences Acquisition in Major Diagnostics Expansion

Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests,  announced th...

February 24, 2026 | Tuesday | News
Altesa BioSciences Raises $75 Million Series B Led by Forbion to Advance First-in-Class Rhinovirus Therapy Vapendavir into Phase 2b

  -Financing led by Forbion, joined by Sanofi and existing investors Medicxi, Pitango, and Atlantic Partners- -Proceeds to advance vapendavir, a fir...

February 23, 2026 | Monday | News
Stellaromics Launches Pyxa™, the First Commercial Platform for Multiplexed 3D Spatial Transcriptomics in Intact Tissue

Stellaromics launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100...

February 23, 2026 | Monday | News
SkylineDx’s Merlin CP-GEP Becomes First Molecular Test Recognized in National Comprehensive Cancer Network Melanoma Guidelines for SLNB Risk Assessment

Merlin CP-GEP is the only molecular test recognized by NCCN as predictive and appropriate for use in select T1 and T2 patients to support shared d...

February 23, 2026 | Monday | News
Sōlaria Biō Reports Clinical Evidence Confirming Gut Delivery and Viability of Bōndia™ Synbiotic Medical Food for Bone Health

Sōlaria Biō, a biotechnology company pioneering natural solutions for healthy aging, recently published the findings of a new open-label, randomized cl...

February 23, 2026 | Monday | Reports
Johnson & Johnson’s TREMFYA® Delivers Durable Remission in Ulcerative Colitis, with Over 80% of Patients Maintaining Clinical Remission Through Week 140

More than 80% of those treated with TREMFYA® were in clinical remission and more than 50% were in endoscopic remission at Week 14...

February 23, 2026 | Monday | News
Rezon Bio Secures U.S. Food and Drug Administration Approval for Commercial Biosimilar Manufacturing at Warsaw-Duchnice Facility

Rezon Bio announces that its Warsaw-Duchnice facility has received approval from the U.S. Food and Drug Administration (FDA) for the commercial manufactu...

February 20, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close